Home |
Free Dividend Report |
BNTX Dividend History |
BNTX Stock Split History |
Preferred Stock Newsletter |
BNTX Options Chain |
Stock Message Boards |
BioNTech SE (BNTX) has 0 splits in our BioNTech SE stock split history database.
Looking at the BioNTech SE stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioNTech SE shares, starting with a $10,000 purchase of BNTX, presented on a split-history-adjusted basis factoring in the complete BioNTech SE stock split history.
Growth of $10,000.00 With Dividends Reinvested |
|||
Start date: | 10/11/2019 | ||
End date: | 05/06/2024 | ||
Start price/share: | $13.82 | ||
End price/share: | $93.35 | ||
Starting shares: | 723.59 | ||
Ending shares: | 733.23 | ||
Dividends reinvested/share: | $2.11 | ||
Total return: | 584.47% | ||
Average Annual Total Return: | 52.30% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $68,456.40 | ||
Years: | 4.57 | ||
Growth of $10,000.00 Without Dividends Reinvested |
|||
Start date: | 10/11/2019 | ||
End date: | 05/06/2024 | ||
Start price/share: | $13.82 | ||
End price/share: | $93.35 | ||
Dividends collected/share: | $2.11 | ||
Total return: | 590.75% | ||
Average Annual Total Return: | 52.60% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $69,075.17 | ||
Years: | 4.57 |
About BioNTech SE |
BioNTech develops immunotherapies for cancer and other diseases. Co.'s immunotherapy product candidates span the following four drug classes: messenger ribonucleic acid (mRNA) therapeutics, in which it is utilizing mRNA to deliver genetic information to cells; cell therapies, in which it is developing a range of cell therapies, including chimeric antigen receptorT cells, neoantigen-based T cell therapies and T cell receptor therapies; antibodies, in which it is developing antibodies that are designed to target immune checkpoints that modulate the patient's immune response to cancer; and small molecule immunomodulators, which is for the treatment of solid tumors in clinical testing. According to our BioNTech SE stock split history records, BioNTech SE has had 0 splits. |
BNTX Split History Table | |
Date | Ratio |
BioNTech SE Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.